Showing results (271-280 of 2,110) with videos related to
Sort By:
Pageof 211
Toxicology and Applied Pharmacology|December 1, 1991
2,5-Hexanedione exposure alters the rat Sertoli cell cytoskeleton. II. Intermediate filaments and actinE S Hall, J Eveleth, K BoekelheideBMC Cardiovascular Disorders|February 5, 2020
The my experience of taking medicines (MYMEDS) questionnaire for assessing medicines adherence barriers in post-myocardial infarction patients: development and utilityRani Khatib, Nasrin Patel, Alistair S HallAnnals of the New York Academy of Sciences|February 12, 2010
Year in review--EROI or energy return on (energy) investedDavid J Murphy, Charles A S HallExperimental Neurology|January 8, 1999
Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factorD L Choi-Lundberg, Q Lin, T Schallert, et al.Internal Medicine Journal|May 31, 2002
Non-prescription complementary treatments used by rheumatoid arthritis patients attending a community-based rheumatology practiceR Buchbinder, M Gingold, S Hall, et al.Journal of Applied Behavior Analysis|April 25, 2001
Effects of social proximity on multiple aggressive behaviorsC Oliver, G Oxener, M Hearn, et al.Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|November 1, 1982
Tympanostomy tubes: do they significantly benefit the patient?G D Smyth, C C Patterson, S HallMicroscopy Research and Technique|December 15, 1995
Distribution of Sertoli cell microtubules, microtubule-dependent motors, and the Golgi apparatus before and after tight junction formation in developing rat testisD M Redenbach, E S Hall, K BoekelheideEuropean Journal of Cell Biology|March 1, 1996
Kinesin localizes to the trans-Golgi network regardless of microtubule organizationK J Johnson, E S Hall, K BoekelheidePharmacology & Toxicology|November 1, 1990
Verapamil potentiates 4'-epidoxorubicin cytotoxicity in a rat hepatoma cell line and in a substrain resistant to 4'-epidoxorubicinK S Hall, L Endresen, H E RugstadPageof 211